# EDGAR Filing Document

**Accession Number:** 0001590714
**File Stem:** 0001590714-26-000041
**Filing Date:** 2026-4
**Character Count:** 132338
**Document Hash:** 4c26590d564db8633196f2b92d15544c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001590714-26-000041.hdr.sgml**: 20260429

**ACCESSION NUMBER**: 0001590714-26-000041

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 75

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260429

**DATE AS OF CHANGE**: 20260429

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Element Solutions Inc
- **CENTRAL INDEX KEY:** 0001590714
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS CHEMICAL PRODUCTS [2890]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 371744899
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36272
- **FILM NUMBER:** 26916269

**BUSINESS ADDRESS:**
- **STREET 1:** 500 S POINTE DRIVE
- **STREET 2:** SUITE 200
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139
- **BUSINESS PHONE:** 561-207-9600

**MAIL ADDRESS:**
- **STREET 1:** 500 S POINTE DRIVE
- **STREET 2:** SUITE 200
- **CITY:** MIAMI BEACH
- **STATE:** FL
- **ZIP:** 33139

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Platform Specialty Products Corp
- **DATE OF NAME CHANGE:** 20131031

?xml version='1.0' encoding='ASCII'? esi-20260331

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_______________

**FORM 10-Q** 

_______________

☒&nbsp;&nbsp;&nbsp;&nbsp;**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended March 31, 2026**

**OR**

☐&nbsp;&nbsp;&nbsp;&nbsp;**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> to <u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

**Commission file number: 001-36272**![Image2.jpg](esi-20260331_g1.jpg)

**Element Solutions Inc** 

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **Delaware** | **37-1744899** |
| (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| **500 S Pointe Drive, Suite 200** | **500 S Pointe Drive, Suite 200** | **33139** |
| **Miami Beach,** | **Florida** | (Zip Code) |
| (Address of principal executive offices) | (Address of principal executive offices) | |

---

Registrant's telephone number, including area code: **(561) 207-9600** 

**_______________**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | ESI | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ &nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer  | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Number of shares of common stock outstanding at April 22, 2026: 243,607,198

------

**<u>**TABLE OF CONTENTS**</u>**

---

| | | |
|:---|:---|:---|
|  | | **Page** |
| | **<u>[Glossary of Defined Terms](#i2b356d9fe8e64a5687dfbdff3e584385_10)</u>** | <u>[i](#i2b356d9fe8e64a5687dfbdff3e584385_10)</u> |
| | **<u>[Forward-Looking Statements](#i2b356d9fe8e64a5687dfbdff3e584385_13)</u>**  | <u>[ii](#i2b356d9fe8e64a5687dfbdff3e584385_13)</u> |
| | **<u>[Non-GAAP Financial Measures](#i2b356d9fe8e64a5687dfbdff3e584385_16)</u>**  | <u>[ii](#i2b356d9fe8e64a5687dfbdff3e584385_16)</u> |
| **<u>[Part I.](#i2b356d9fe8e64a5687dfbdff3e584385_19)</u>** | **<u>[Financial Information](#i2b356d9fe8e64a5687dfbdff3e584385_19)</u>** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 1.](#i2b356d9fe8e64a5687dfbdff3e584385_22)</u>** | **<u>[Condensed Consolidated Financial Statements (Unaudited)](#i2b356d9fe8e64a5687dfbdff3e584385_22)</u>** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Condensed Consolidated Statements of Operations](#i2b356d9fe8e64a5687dfbdff3e584385_25)</u>** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Three Months Ended March 31, 2026 and 2025</u>** | <u>[1](#i2b356d9fe8e64a5687dfbdff3e584385_25)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Condensed Consolidated Statements of Comprehensive Income](#i2b356d9fe8e64a5687dfbdff3e584385_28)</u>** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Three Months Ended March 31, 2026 and 2025</u>** | <u>[2](#i2b356d9fe8e64a5687dfbdff3e584385_28)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Condensed Consolidated Balance Sheets](#i2b356d9fe8e64a5687dfbdff3e584385_31)</u>** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>March 31, 2026 and December 31, 2025</u>** | <u>[3](#i2b356d9fe8e64a5687dfbdff3e584385_31)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Condensed Consolidated Statements of Cash Flows](#i2b356d9fe8e64a5687dfbdff3e584385_34)</u>** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Three Months Ended March 31, 2026 and 2025</u>** | <u>[4](#i2b356d9fe8e64a5687dfbdff3e584385_34)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Condensed Consolidated Statements of Changes in Stockholders' Equity](#i2b356d9fe8e64a5687dfbdff3e584385_37)</u>** |  |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>Three Months Ended March 31, 2026 and 2025</u>** | <u>[5](#i2b356d9fe8e64a5687dfbdff3e584385_37)</u> |
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>[Notes to the Condensed Consolidated Financial Statements](#i2b356d9fe8e64a5687dfbdff3e584385_40)</u>** | <u>[6](#i2b356d9fe8e64a5687dfbdff3e584385_40)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 2.](#i2b356d9fe8e64a5687dfbdff3e584385_94)</u>** | **<u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i2b356d9fe8e64a5687dfbdff3e584385_94)</u>** | <u>[20](#i2b356d9fe8e64a5687dfbdff3e584385_94)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 3.](#i2b356d9fe8e64a5687dfbdff3e584385_136)</u>** | **<u>[Quantitative and Qualitative Disclosures About Market Risk](#i2b356d9fe8e64a5687dfbdff3e584385_136)</u>** | <u>[30](#i2b356d9fe8e64a5687dfbdff3e584385_136)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 4.](#i2b356d9fe8e64a5687dfbdff3e584385_139)</u>** | **<u>[Controls and Procedures](#i2b356d9fe8e64a5687dfbdff3e584385_139)</u>** | <u>[30](#i2b356d9fe8e64a5687dfbdff3e584385_139)</u> |
| **<u>[Part II.](#i2b356d9fe8e64a5687dfbdff3e584385_142)</u>** | **<u>[Other Information](#i2b356d9fe8e64a5687dfbdff3e584385_142)</u>** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 1.](#i2b356d9fe8e64a5687dfbdff3e584385_145)</u>** | **<u>[Legal Proceedings](#i2b356d9fe8e64a5687dfbdff3e584385_145)</u>** | <u>[31](#i2b356d9fe8e64a5687dfbdff3e584385_145)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 1A.](#i2b356d9fe8e64a5687dfbdff3e584385_148)</u>** | **<u>[Risk Factors](#i2b356d9fe8e64a5687dfbdff3e584385_148)</u>** | <u>[31](#i2b356d9fe8e64a5687dfbdff3e584385_148)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 2.](#i2b356d9fe8e64a5687dfbdff3e584385_151)</u>** | **<u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i2b356d9fe8e64a5687dfbdff3e584385_151)</u>** | <u>[31](#i2b356d9fe8e64a5687dfbdff3e584385_151)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 3.](#i2b356d9fe8e64a5687dfbdff3e584385_154)</u>** | **<u>[Defaults Upon Senior Securities](#i2b356d9fe8e64a5687dfbdff3e584385_154)</u>** | <u>[31](#i2b356d9fe8e64a5687dfbdff3e584385_154)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 4.](#i2b356d9fe8e64a5687dfbdff3e584385_157)</u>** | **<u>[Mine Safety Disclosures](#i2b356d9fe8e64a5687dfbdff3e584385_157)</u>** | <u>[31](#i2b356d9fe8e64a5687dfbdff3e584385_157)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 5.](#i2b356d9fe8e64a5687dfbdff3e584385_160)</u>** | **<u>[Other Information](#i2b356d9fe8e64a5687dfbdff3e584385_160)</u>** | <u>[31](#i2b356d9fe8e64a5687dfbdff3e584385_160)</u> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**<u>[Item 6.](#i2b356d9fe8e64a5687dfbdff3e584385_166)</u>** | **<u>[Exhibits](#i2b356d9fe8e64a5687dfbdff3e584385_166)</u>** | <u>[32](#i2b356d9fe8e64a5687dfbdff3e584385_166)</u> |
| **<u>[Signatures](#i2b356d9fe8e64a5687dfbdff3e584385_169)</u>** | **<u>[Signatures](#i2b356d9fe8e64a5687dfbdff3e584385_169)</u>** | <u>[33](#i2b356d9fe8e64a5687dfbdff3e584385_169)</u> |

---

------

**GLOSSARY OF DEFINED TERMS**

---

| | |
|:---|:---|
| **Terms**&nbsp;&nbsp;&nbsp;&nbsp; | **Definitions** |
| ***Element Solutions;<br>We; Us; Our; the Company*** | Element Solutions Inc, a Delaware corporation, and where the context requires, its subsidiaries or operating businesses. |
| ***Add-on Term Loans*** | Element Solutions' $450 million aggregate principal amount of incremental term loans B borrowed under the Credit Agreement on February 2, 2026.  |
| ***Credit Agreement*** | Credit Agreement, dated as of January 31, 2019, as amended from time to time, among, inter alia, Element Solutions and MacDermid, Incorporated, as borrowers, certain subsidiaries of Element Solutions, as guarantors, and the lenders from time to time parties thereto. |
| ***EBITDA*** | Earnings before interest, taxes, depreciation and amortization. |
| ***EFC Acquisition*** | Element Solutions' acquisition of EFC Gases & Advanced Materials ("EFC") on January 2, 2026. |
| ***Electronics*** | Element Solutions' MacDermid Alpha Electronics Solutions business segment. |
| ***Exchange Act*** | Securities Exchange Act of 1934, as amended. |
| ***GAAP*** | U.S. Generally Accepted Accounting Principles. |
| ***Kuprion Acquisition*** | Element Solutions' acquisition of Kuprion, Inc. on May 19, 2023. |
| ***Micromax Acquisition*** | Element Solutions' acquisition of Micromax (US) Holdings LLC ("Micromax") on February 2, 2026. |
| ***MGS Transaction*** | Element Solutions' sale of its flexographic printing plate business, MacDermid Graphics Solutions, on February 28, 2025. |
| ***Quarterly Report*** | This quarterly report on Form 10-Q for the three months ended March 31, 2026. |
| ***RSUs*** | Restricted stock units issued by Element Solutions from time to time under its Amended and Restated 2013 Incentive Compensation Plan or 2024 Incentive Compensation Plan, as applicable. |
| ***SEC*** | Securities and Exchange Commission. |
| ***Specialties*** | Element Solutions' Element Specialties business segment. |
| ***2025 Annual Report*** | Element Solutions' annual report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 18, 2026. |
| ***3.875% USD Notes due 2028*** | Element Solutions' $800 million aggregate principal amount of 3.875% senior notes due 2028, denominated in U.S. dollars, issued on August 18, 2020. |

---

i

------

**Forward-Looking Statements** 

This Quarterly Report contains forward-looking statements that can be identified by words such as "expect," "anticipate," "project," "will," "should," "believe," "intend," "plan," "assume," "estimate," "predict," "seek," "continue," "outlook," "may," "might," "aim," "can have," "likely," "potential," "target," "hope," "goal," "priority" or "confident" and variations of such words and similar expressions. Many of the forward-looking statements include, but are not limited to, statements, beliefs, projections and expectations regarding the expected benefits of the Kuprion Acquisition, the MGS Transaction, the EFC Acquisition and the Micromax Acquisition; the tax treatment and tax implications of the MGS Transaction; EFC's earn-out and probability of achievement of the performance targets related to certain EFC performance-based RSUs; deferred payments related to the Kuprion Acquisition; the war in Ukraine, the Iran conflict and other hostilities in the Middle East as well as actions in response thereto and their impact on market conditions and the global economy; increases in tariffs and/or imposition of new tariffs and other changes in trade policy in the U.S. and other countries, and other economic factors that may affect cost structure and demand, including the cost and availability of raw materials and precious metals; capital requirements and need for and availability of financing; the impact of government regulations on our ability to conduct operations; the impact of new accounting standards and accounting changes; potential share repurchases; our dividend policy and dividend declarations; our hedging activities; timing and outcome of environmental and legal matters; tax planning strategies and assessments; the impact of changes to privacy, cybersecurity, environmental, global trade, tax and other governmental regulations; impairments, including those on goodwill and other intangible assets; price volatility and cost environment; inflation and fluctuations in foreign exchange rates; our liquidity, cash flows and capital allocation; funding sources; expected capital expenditures; debt and debt leverage ratio; pension plan contributions; contractual obligations; general views about future operating results; sustainability goals; expected returns to stockholders; risk management programs; future prospects; and other events or developments that we expect or anticipate will occur in the future.

Although we believe these forward-looking statements are based upon reasonable assumptions regarding our business and expectations about future events, financial performance and trends, there can be no assurance that our actual results will not differ materially from any results expressed or implied in these forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in Part I, Item 1A, *Risk Factors,* of our 2025 Annual Report. In addition, as we operate in a very competitive and rapidly changing environment, new risks may emerge from time to time. Any forward-looking statement included in this Quarterly Report is based solely on information currently available and speaks only as of the date on which it is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Please consult any further disclosures on related subjects in our SEC filings.

**Non-GAAP Financial Measures** 

This Quarterly Report contains non-GAAP financial measures, such as Adjusted EBITDA, Adjusted EBITDA margin and operating results on a constant currency and organic basis. Non-GAAP financial measures should not be considered in isolation from, a substitute for, or superior to, performance measures calculated in accordance with GAAP. For additional information on these non-GAAP financial measures, including definitions, limitations and reconciliations to their most comparable applicable GAAP measures, see "*Non-GAAP Financial Measures*" in Part I, Item 2 *Management's Discussion and Analysis of Financial Condition and Results of Operations*, and Note 12, *Segment Information*, to the unaudited Condensed Consolidated Financial Statements, both included in this Quarterly Report.

ii

------

**PART I. FINANCIAL INFORMATION**

**Item 1. Condensed Consolidated Financial Statements**

**ELEMENT SOLUTIONS INC AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Unaudited)**

**(dollars in millions, except per share amounts)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| **Net sales** | $840.0 | $593.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 517.3 | 343.2 |
| **Gross profit** | 322.7 | 250.5 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, technical, general and administrative | 191.1 | 157.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 20.2 | 15.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 211.3 | 173.1 |
| **Operating profit** | 111.4 | 77.4 |
| Other (expense) income: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (21.5) | (14.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange losses | (0.9) | (6.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (6.3) | (13.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures |  | 72.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other (expense) income | (28.7) | 38.4 |
| **Income before income taxes and non-controlling interests** | 82.7 | 115.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | (26.7) | (17.8) |
| **Net income** | 56.0 | 98.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to non-controlling interests | (0.1) |  |
| **Net income attributable to common stockholders** | $55.9 | $98.0 |
| **<u>Earnings per share</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.23 | $0.40 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.23 | $0.40 |
| **<u>Weighted average common shares outstanding</u>** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 243.2 | 242.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 243.7 | 243.0 |

---

***See accompanying notes to the Condensed Consolidated Financial Statements***

------

**ELEMENT SOLUTIONS INC AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME**

**(Unaudited)**

**(dollars in millions)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| **Net income** | $56.0 | $98.0 |
| **Other comprehensive income (loss)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Foreign currency translation:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income before reclassifications, net of tax expense (benefit) of $6.2 and $(6.9) for the three months ended March 31, 2026 and 2025, respectively | 10.1 | 38.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassifications, net of tax benefit of $0.0 and $0.8 for the three months ended March 31, 2026 and 2025, respectively |  | 29.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total foreign currency translation adjustments | 10.1 | 68.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Derivative financial instruments:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications, net of tax expense (benefit) of $1.7 and $(2.9) for the three months ended March 31, 2026 and 2025, respectively | 5.9 | (9.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassifications, net of tax benefit of $0.0 and $0.3 for the three months ended March 31, 2026 and 2025, respectively | (0.1) | (1.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total unrealized gain (loss) on qualified hedging derivatives | 5.8 | (10.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Other comprehensive income** | 15.9 | 57.5 |
| **Comprehensive income** | 71.9 | 155.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Comprehensive income attributable to non-controlling interests |  | 0.1 |
| **Comprehensive income attributable to common stockholders** | $71.9 | $155.6 |

---

***See accompanying notes to the Condensed Consolidated Financial Statements***

------

**ELEMENT SOLUTIONS INC AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(Unaudited)**

**(dollars in millions)**

---

| | | |
|:---|:---|:---|
| | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| **Assets** |  |  |
| Cash and cash equivalents | $177.3 | $626.5 |
| Accounts receivable, net of allowance for doubtful accounts of $10.0 and $9.4 at March 31, 2026 and December 31, 2025, respectively | 676.9 | 517.7 |
| Inventories | 421.6 | 294.7 |
| Prepaid expenses | 30.0 | 28.3 |
| Other current assets | 152.6 | 115.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current assets** | 1458.4 | 1582.5 |
| Property, plant and equipment, net | 403.3 | 319.6 |
| Goodwill | 2535.5 | 2241.9 |
| Intangible assets, net | 1029.4 | 657.2 |
| Deferred income tax assets | 166.0 | 175.5 |
| Other assets | 145.2 | 124.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total assets** | $5737.8 | $5101.4 |
| **Liabilities and stockholders' equity** |  |  |
| Accounts payable | $180.8 | $165.5 |
| Current installments of long-term debt and revolving credit facilities | 97.9 |  |
| Accrued expenses and other current liabilities | 264.9 | 264.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total current liabilities** | 543.6 | 429.9 |
| Debt | 2058.7 | 1625.9 |
| Pension and post-retirement benefits | 21.5 | 22.3 |
| Deferred income tax liabilities | 109.8 | 93.1 |
| Other liabilities | 254.4 | 240.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities** | 2988.0 | 2412.0 |
| Commitments and contingencies (Note 9) |  |  |
| **Stockholders' equity** |  |  |
| Preferred stock - Series A |  |  |
| Common stock: 400.0 shares authorized (2026: 270.5 shares issued; 2025: 269.6 shares issued) | 2.7 | 2.7 |
| Additional paid-in capital | 4287.7 | 4279.2 |
| Treasury stock (2026: 26.9 shares; 2025: 26.9 shares) | (394.0) | (393.9) |
| Accumulated deficit | (868.5) | (904.6) |
| Accumulated other comprehensive loss | (292.9) | (308.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total stockholders' equity** | 2735.0 | 2674.5 |
| Non-controlling interests | 14.8 | 14.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total equity** | 2749.8 | 2689.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total liabilities and stockholders' equity** | $5737.8 | $5101.4 |

---

***See accompanying notes to the Condensed Consolidated Financial Statements***

------

**ELEMENT SOLUTIONS INC AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

**(dollars in millions)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| **Cash flows from operating activities:** |  |  |
| Net income | $56.0 | $98.0 |
| Reconciliations of net income to net cash flows (used in) provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 42.5 | 37.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 1.7 | (4.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange (gains) losses | (0.3) | 5.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Incentive stock compensation | 8.1 | 5.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures |  | (72.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;EFC contingent consideration | 5.9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 5.4 | 4.5 |
| Changes in assets and liabilities, net of acquisitions and divestitures: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (81.8) | (12.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | (93.2) | (18.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 11.3 | 19.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 7.0 | (44.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (11.8) | (4.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities | (17.4) | 13.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash flows (used in) provided by operating activities** | (66.6) | 26.0 |
| **Cash flows from investing activities:** |  |  |
| Capital expenditures | (25.1) | (11.0) |
| Proceeds from disposal of property, plant and equipment |  | 0.1 |
| Proceeds from divestitures (net of cash of $2.5 million) |  | 322.9 |
| Acquisitions, net of cash acquired | (864.2) |  |
| Other, net |  | 25.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash flows (used in) provided by investing activities** | (889.3) | 337.6 |
| **Cash flows from financing activities:** |  |  |
| Debt proceeds, net of discount | 449.4 |  |
| Repayments of borrowings |  | (202.6) |
| Changes in lines of credit, net | 85.0 |  |
| Dividends | (20.2) | (19.8) |
| Payment of financing fees | (6.1) |  |
| Other, net | (0.3) | (4.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net cash flows provided by (used in) financing activities** | 507.8 | (227.3) |
| Effect of exchange rate changes on cash and cash equivalents | (1.1) | 3.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net (decrease) increase in cash and cash equivalents** | (449.2) | 139.8 |
| Cash and cash equivalents at beginning of period | 626.5 | 359.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Cash and cash equivalents at end of period** | $177.3 | $499.2 |

---

***See accompanying notes to the Condensed Consolidated Financial Statements***

------

**ELEMENT SOLUTIONS INC AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

**(Unaudited)**

**(dollars in millions, except share amounts)**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended March 31, 2026** | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Treasury Stock** | **Treasury Stock** | **Accumulated<br>Deficit** | **Accumulated Other Comprehensive (Loss) Income** | **Total<br>Stockholders'<br>Equity** | **Non-<br>controlling Interests** | **Total Equity** |
| **Three Months Ended March 31, 2026** | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Shares** | **Amount** | **Accumulated<br>Deficit** | **Accumulated Other Comprehensive (Loss) Income** | **Total<br>Stockholders'<br>Equity** | **Non-<br>controlling Interests** | **Total Equity** |
| **Balance at December 31, 2025** | 269596952 | $2.7 | $4279.2 | 26867999 | $(393.9) | $(904.6) | $(308.9) | $2674.5 | $14.9 | $2689.4 |
| Net income |  |  |  |  |  | 55.9 |  | 55.9 | 0.1 | 56.0 |
| Other comprehensive income (loss), net of taxes |  |  |  |  |  |  | 16.0 | 16.0 | (0.1) | 15.9 |
| Exercise/ vesting of stock-based compensation | 865220 |  |  | 2134 |  |  |  |  |  |  |
| Issuance of common stock under Employee Stock Purchase Plan | 16754 |  | 0.3 |  |  |  |  | 0.3 |  | 0.3 |
| Repurchases of common stock |  |  |  | 3071 | (0.1) |  |  | (0.1) |  | (0.1) |
| Dividends ($0.08 per share) |  |  |  |  |  | (19.8) |  | (19.8) |  | (19.8) |
| Equity compensation expense |  |  | 8.2 |  |  |  |  | 8.2 |  | 8.2 |
| Changes in non-controlling interests |  |  |  |  |  |  |  |  | (0.1) | (0.1) |
| **Balance at March 31, 2026** | 270478926 | $2.7 | $4287.7 | 26873204 | $(394.0) | $(868.5) | $(292.9) | $2735.0 | $14.8 | $2749.8 |

---

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended March 31, 2025** | **Common Stock** | **Common Stock** | **Additional<br>Paid-in<br>Capital** | **Treasury Stock** | **Treasury Stock** | **Accumulated<br>Deficit** | **Accumulated Other Comprehensive (Loss) Income** | **Total<br>Stockholders'<br>Equity** | **Non-<br>controlling Interests** | **Total Equity** |
| **Three Months Ended March 31, 2025** | **Shares** | **Amount** | **Additional<br>Paid-in<br>Capital** | **Shares** | **Amount** | **Accumulated<br>Deficit** | **Accumulated Other Comprehensive (Loss) Income** | **Total<br>Stockholders'<br>Equity** | **Non-<br>controlling Interests** | **Total Equity** |
| **Balance at December 31, 2024** | 267154474 | $2.7 | $4214.1 | 24972401 | $(349.5) | $(1017.1) | $(467.2) | $2383.0 | $15.4 | $2398.4 |
| Net income |  |  |  |  |  | 98.0 |  | 98.0 |  | 98.0 |
| Other comprehensive income (loss), net of taxes |  |  |  |  |  |  | 57.6 | 57.6 | (0.1) | 57.5 |
| Exercise/ vesting of stock-based compensation | 490560 |  |  | 185189 | (4.8) |  |  | (4.8) |  | (4.8) |
| Issuance of common stock under Employee Stock Purchase Plan | 16511 |  | 0.4 |  |  |  |  | 0.4 |  | 0.4 |
| Dividends ($0.08 per share) |  |  |  |  |  | (19.5) |  | (19.5) |  | (19.5) |
| Equity compensation expense |  |  | 5.1 |  |  |  |  | 5.1 |  | 5.1 |
| Changes in non-controlling interests |  |  |  |  |  |  |  |  | (0.1) | (0.1) |
| **Balance at March 31, 2025** | 267661545 | $2.7 | $4219.6 | 25157590 | $(354.3) | $(938.6) | $(409.6) | $2519.8 | $15.2 | $2535.0 |

---

***See accompanying notes to the Condensed Consolidated Financial Statements***

------

**ELEMENT SOLUTIONS INC AND SUBSIDIARIES**

**Notes to the Condensed Consolidated Financial Statements**

**(Unaudited)**

**1. BACKGROUND AND BASIS OF PRESENTATION**

**Background**

Element Solutions was incorporated in Delaware in January 2014 and its shares of common stock, par value $0.01 per share, trade on the New York Stock Exchange under the ticker symbol "ESI."

Element Solutions is a leading global specialty chemicals technology company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. Developed in multi-step technological processes, these innovative solutions enable customers' manufacturing processes in multiple high-value industries, including semiconductor fabrication, high-performance computing, automotive systems, consumer electronics, power electronics, communications and data storage infrastructure, aerospace and defense, industrial surface finishing and offshore energy. Element Solutions businesses provide products that, in substantially all cases, are consumed by customers as part of their production process, providing the Company with reliable and recurring revenue streams as the products are replenished in order to continue production. Element Solutions delivers its products to customers through its sales and service workforce, regional distributors and manufacturing representatives.

The Company's operations are organized in two reportable segments: Electronics (MacDermid Alpha Electronics Solutions) and Specialties (Element Specialties). The reportable segments represent businesses for which separate financial information is utilized by the chief operating decision maker for the purpose of allocating resources and evaluating performance.

***Electronics*** – The Electronics segment researches, formulates and sells specialty chemicals and material process technologies for all types of electronics hardware, from complex printed circuit board designs to advanced semiconductor packaging. In high-performance datacenters, mobile communications, computers, automobiles and aerospace equipment, its products are an integral part of the electronics manufacturing process and the functionality of end-products. The segment's "wet chemistries" for metallization, surface treatments and solderable finishes form the physical circuitry pathways, and its "assembly materials," such as surface mount technologies ("SMT"), pastes, fluxes and adhesives, join those pathways together. The segment provides specialty chemicals solutions through the following businesses: Assembly Solutions, Circuitry Solutions, Micromax and Semiconductor Solutions.

***Specialties*** – The Specialties segment researches, formulates and sells specialty chemicals and material process technologies that enable or enhance the performance of high value products across diverse sectors from automotive to energy infrastructure to semiconductors and satellites. Its products include chemical systems that protect and decorate metal and plastic surfaces, chemistries used in water-based hydraulic control fluids for offshore energy production and rare or high-purity gases and advanced materials used in semiconductor fabrication, satellite systems, electrical transmission infrastructure and other end-markets. The segment provides specialty chemicals solutions through the following businesses: Industrial Solutions, EFC and Energy Solutions. On February 28, 2025, the Company completed the sale of its flexographic printing plate business, MacDermid Graphics Solutions.

**Basis of Presentation**

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with GAAP and include the accounts of Element Solutions and all of its controlled subsidiaries. The Company consolidates the income, expenses, assets, liabilities and cash flows of its subsidiaries from the date it acquires control or becomes the primary beneficiary. All intercompany accounts and transactions have been eliminated upon consolidation.

In preparing the unaudited Condensed Consolidated Financial Statements in conformity with GAAP, management uses estimates and assumptions that may affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting period. Management applies judgment based on its understanding and analysis of the relevant circumstances, including historical experience and future expectations. These judgments, by their nature, are subject to an inherent degree of uncertainty and, accordingly, actual results could differ significantly from these estimates and assumptions.

------

These unaudited Condensed Consolidated Financial Statements reflect all adjustments that are normal, recurring and necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2026. These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company's Consolidated Financial Statements and related notes included in its 2025 Annual Report.

Certain prior year amounts have been reclassified to conform to the current year's presentation.

**2. ACQUISITIONS**

*Micromax Acquisition*

On February 2, 2026, the Company completed the Micromax Acquisition for a purchase price of approximately $493 million, net of cash and subject to adjustments. Micromax is a global supplier of advanced electronics inks and pastes and was acquired to complement the Company's electronics portfolio. This acquisition was funded with the proceeds from the Add-on Term Loans of $450 million, which closed simultaneously with the Micromax Acquisition, and borrowings under the Company's revolving credit facility. Micromax is reported in the Company's Electronics segment.

*EFC Acquisition*

On January 2, 2026, the Company completed the EFC Acquisition for a purchase price of approximately $367 million, net of cash and subject to adjustments, with an additional $16.1 million estimated fair value associated with a potential earn-out based on EFC's 2026 performance of up to $30.0 million cash or 1.16 million shares of the Company's common stock. EFC is a provider of high-purity specialty gases and other advanced materials and was acquired to complement the Company's industrial portfolio. This acquisition was funded with cash on hand. EFC is reported in the Company's Specialties segment.

In connection with the EFC Acquisition, certain EFC executives were granted approximately 1.45 million performance-based RSUs with an aggregate grant date fair value of $37.5 million. These RSUs were granted in two tranches with vesting subject to the achievement of EFC's Adjusted EBITDA performance targets for 2028 and 2030. The actual number of shares of the Company's common stock to be issued under these grants will range between 0% and 150% depending on the applicable Adjusted EBITDA performance level achieved in 2028 or 2030. If EFC's Adjusted EBITDA target level for any tranche is not achieved in the relevant year, the vesting of that tranche will be delayed by one year and EFC's Adjusted EBITDA generated that following year will be used to assess performance capped at 100%. As of March 31, 2026, the Company believes the achievement of these targets is probable and recognized $1.8 million of compensation expense for these awards in "Selling, technical, general and administrative" in the Condensed Consolidated Statement of Operations during the first quarter of 2026.

------

The following table summarizes the allocation of the purchase price of the Micromax and EFC Acquisitions (together, the "Acquisitions") to the identified assets acquired and liabilities assumed at the respective acquisition dates:

---

| | | |
|:---|:---|:---|
| *(dollars in millions)* | **Micromax** | **EFC** |
| **Consideration** |  |  |
| &nbsp;&nbsp;Cash, net | $492.7 | $366.9 |
| &nbsp;&nbsp;Contingent consideration (See Note 7, *Financial Instruments)* |  | 16.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total consideration** | $492.7 | $383.0 |
| **Identifiable assets acquired and liabilities assumed** |  |  |
| &nbsp;&nbsp;Accounts receivable | $70.8 | $10.3 |
| &nbsp;&nbsp;Inventories | 25.2 | 13.8 |
| &nbsp;&nbsp;Other current assets | 15.1 | 1.2 |
| &nbsp;&nbsp;Property, plant and equipment | 56.8 | 31.4 |
| &nbsp;&nbsp;Identifiable intangible assets | 230.0 | 172.0 |
| &nbsp;&nbsp;Other assets | 20.9 | 3.2 |
| &nbsp;&nbsp;Current liabilities | (23.5) | (10.6) |
| &nbsp;&nbsp;Deferred income taxes | (18.1) |  |
| &nbsp;&nbsp;Other long-term liabilities | (17.5) | (2.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total identifiable net assets** | 359.7 | 219.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Goodwill** | 133.0 | 163.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total purchase price** | $492.7 | $383.0 |

---

The excess of the cost of the Acquisitions over the net amounts assigned to the fair value of the assets acquired and the liabilities assumed was recorded as goodwill and represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. Substantially all of the goodwill for EFC and approximately $85.0 million for Micromax is expected to be deductible for tax purposes.

The fair value of the identifiable intangible assets recorded in conjunction with the Acquisitions was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Micromax** | **Micromax** | **EFC** | **EFC** |
| *(dollars in millions)* | **Fair Value** | **Weighted Average Useful Life *(years)*** | **Fair Value** | **Weighted Average Useful Life *(years)*** |
| Customer relationships | $165.0 | 12 | $120.0 | 10 |
| Trade name | 20.0 | 8 | 10.0 | 10 |
| Developed technology | 45.0 | 8 | 42.0 | 10 |
| &nbsp;&nbsp;**Total** | $230.0 | 11 | $172.0 | 10 |

---

The fair value of the identifiable intangible assets was determined primarily using the "income approach," which requires a forecast of all of the expected future cash flows, either through the use of the multi-period excess earnings method or the relief-from-royalty method. Some of the more significant assumptions inherent in the development of intangible asset values include the amount and timing of projected future cash flows, the attrition rate and the discount rate selected to measure the risks inherent in the future cash flows.

The deferred income taxes reflect the tax effect of the differences between the carry-over tax basis and the fair value recorded in purchase accounting that are primarily associated with the recognition of identifiable intangible assets.

As of March 31, 2026, the purchase price allocation for each of the Acquisitions is preliminary. We expect to complete the purchase price allocation within the applicable one year measurement period.

------

The Acquisitions were not significant to our Condensed Consolidated Financial Statements; therefore, pro forma and post acquisition results of operations have not been presented.

**3. INVENTORIES**

The major components of inventory, on a net basis, were as follows:

---

| | | |
|:---|:---|:---|
| *(dollars in millions)* | **March 31, 2026** | **December 31, 2025** |
| Finished goods | $212.5 | $152.7 |
| Work in process | 88.7 | 57.9 |
| Raw materials and supplies | 120.4 | 84.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total inventories** | $421.6 | $294.7 |

---

**4. PROPERTY, PLANT AND EQUIPMENT, NET**

The major components of property, plant and equipment, net were as follows:

---

| | | |
|:---|:---|:---|
| *(dollars in millions)* | **March 31, 2026** | **December 31, 2025** |
| Land and leasehold improvements | $67.1 | $48.9 |
| Buildings and improvements | 234.3 | 214.8 |
| Machinery, equipment, fixtures and software | 446.9 | 391.2 |
| Construction in process | 55.4 | 49.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total property, plant and equipment** | 803.7 | 704.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated depreciation | (400.4) | (384.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Property, plant and equipment, net** | $403.3 | $319.6 |

---

For the three months ended March 31, 2026 and 2025, the Company recorded depreciation expense of $14.5 million and $10.0 million, respectively.

**5. GOODWILL AND INTANGIBLE ASSETS, NET**

*Goodwill*

The changes in the carrying amount of goodwill by segment were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in millions)* | **Electronics** | **Specialties** |  | **Total** |
| **Balance at December 31, 2025** | $1315.5 | $926.4 | (1) | $2241.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions <sup>(2)</sup> | 133.0 | 163.6 |  | 296.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation and other | 0.6 | (3.6) |  | (3.0) |
| **Balance at March 31, 2026** | $1449.1 | $1086.4 |  | $2535.5 |

---

*(1) Includes accumulated impairment losses of $46.6 million.* 

*(2) The Company completed the Micromax Acquisition and the EFC Acquisition on February 2, 2026 and January 2, 2026, respectively. See Note 2, Acquisitions, to the unaudited Condensed Consolidated Financial Statements for further information.*

------

*Intangible Assets, Net*

The major components of intangible assets, net were as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| *(dollars in millions)* | **Gross Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net Book<br>Value** | **Gross Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net Book<br>Value** |
| Customer relationships | $1086.1 | $(475.9) | $610.2 | $876.8 | $(532.9) | $343.9 |
| Developed technology | 279.9 | (156.5) | 123.4 | 313.3 | (272.2) | 41.1 |
| Trade names | 193.7 | (49.6) | 144.1 | 163.8 | (46.4) | 117.4 |
| Reacquired distribution rights | 187.0 | (35.3) | 151.7 | 187.0 | (32.2) | 154.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total** | $1746.7 | $(717.3) | $1029.4 | $1540.9 | $(883.7) | $657.2 |

---

For the three months ended March 31, 2026 and 2025, the Company recorded amortization expense on intangible assets of $28.0 million and $27.2 million, respectively.

In the fourth quarter of 2025, a milestone agreed to as part of the Kuprion Acquisition was achieved. As the technology developed met the accounting definition of an asset, the Company capitalized a $6.3 million developed technology intangible asset ($4.9 million milestone payment plus a gross up for deferred taxes of $1.4 million), which is being amortized over 10 years. While the milestone was achieved in the fourth quarter of 2025, the associated payment was made in the first quarter of 2026 and $4.9 million is included in "Acquisitions, net of cash acquired" as a cash outflow from investing activities in the Condensed Consolidated Statements of Cash Flows.

**6. DEBT**

The Company's debt obligations consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in millions)* | **Maturity Date** | **Interest Rate** | **March 31, 2026** | **December 31, 2025** |
| Term Loans <sup>(1)</sup> | 2030 | SOFR plus 1.75% | $1275.6 | $830.3 |
| Senior Notes - $800 million <sup>(2)</sup> | 2028 | 3.875% | 796.0 | 795.6 |
| Borrowings under the Revolving Credit Facility | 2031 | SOFR plus 1.50% | 85.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total debt** | &nbsp;&nbsp;&nbsp;&nbsp;**Total debt** | &nbsp;&nbsp;&nbsp;&nbsp;**Total debt** | 2156.6 | 1625.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: current installments of long-term debt and revolving credit facilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: current installments of long-term debt and revolving credit facilities | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: current installments of long-term debt and revolving credit facilities | 97.9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total long-term debt** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total long-term debt** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total long-term debt** | $2058.7 | $1625.9 |

---

<sup>(1)</sup> *Term loans, net of unamortized discounts and debt issuance costs of $10.6 million and $5.9 million at March 31, 2026 and December 31, 2025, respectively. The effective interest rate was 4.5% at each of March 31, 2026 and December 31, 2025, including the effects of interest rate swaps and net investment hedges. See Note 7, Financial Instruments, to the unaudited Condensed Consolidated Financial Statements for further information regarding the Company's interest rate swaps and net investment hedges.*

<sup>(2)</sup> *Senior notes, net of unamortized debt issuance costs of $4.0 million and $4.4 million at March 31, 2026 and December 31, 2025, respectively. The effective interest rate was 4.1% at both March 31, 2026 and December 31, 2025.*

**Credit Agreement**

The Company is a party to the Credit Agreement which, at March 31, 2026, provided for senior secured credit facilities consisting of a tranche of term loans B-3 of $1.29 billion maturing in 2030, and a revolving credit facility of $500 million, maturing in 2031. The Company's outstanding term loans bear interest at a per annum rate based on an adjusted one-month SOFR (as described in the Credit Agreement) plus a spread of 1.75%.

------

On February 2, 2026, the Company completed the syndication of $450 million of Add-on Term Loans and a 5-year $500 million senior secured revolving credit facility, which replaced its then existing $375 million revolving credit facility, upsizing the facility by $125 million and extending its maturity to 2031. The Add-on Term Loans have identical terms as the then existing term loans B-3, including a maturity date of December 18, 2030. The proceeds of the Add-on Term Loans were used to finance a portion of the purchase price of the Micromax Acquisition. Borrowings under the new revolving credit facility bear interest at Term SOFR (as defined in the Credit Agreement), subject to a rate floor of 0%, plus an applicable margin of 1.50% per annum.

*Guarantees, Covenants and Events of Default* 

The obligations of the borrowers (the Company and its subsidiary, MacDermid, Incorporated) under the Credit Agreement are guaranteed, jointly and severally, by certain of their domestic subsidiaries and secured by a first-priority security interest in substantially all of their assets and the assets of the guarantors, including mortgages on material real property, subject to certain exceptions.

The Credit Agreement contains customary representations and warranties and affirmative and negative covenants, including limitations on additional indebtedness, dividends, and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens on the assets of the borrowers or any guarantor, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. Subject to certain exceptions, to the extent the borrowers have total outstanding borrowings under the revolving credit facility greater than 30% of the commitment amount under the revolving credit facility, the Company's first lien net leverage ratio should not exceed 5.0 to 1.0, subject to a right to cure.

The borrowers are required to make mandatory prepayments of borrowings, subject to certain exceptions, as described in the Credit Agreement. In addition, the Credit Agreement contains customary events of default that include, among others, non-payment of principal, interest or fees, violation of covenants, inaccuracy of representations and warranties, failure to make payment on, or defaults with respect to, certain other material indebtedness, bankruptcy and insolvency events, material judgments and change of control provisions. Upon the occurrence of an event of default, and after the expiration of any applicable grace period, payment of any outstanding loans under the Credit Agreement may be accelerated and the lenders could foreclose on their security interests in the assets of the borrowers and the guarantors.

At March 31, 2026, the Company was in compliance with the debt covenants contained in the Credit Agreement and had full availability of its unused borrowing capacity of $408 million, net of letters of credit, under the revolving credit facility. The Company is required to pay a commitment fee on any undrawn portion of the revolving credit facility which is not material.

**Senior Notes**

*3.875% USD Notes due 2028* 

The indenture governing the 3.875% USD Notes due 2028 provides for, among other things, customary affirmative and negative covenants, events of default and other customary provisions. The notes accrue interest at a rate of 3.875% per annum, payable semi-annually in arrears, on March 1 and September 1 of each year, and will mature on September 1, 2028, unless earlier repurchased or redeemed. Pursuant to the indenture, the Company has the option to redeem the 3.875% USD Notes due 2028 prior to their maturity, subject to, in certain cases, the payment of an applicable make-whole premium, or to repurchase them by any means other than a redemption, including by tender offer, open market purchases or negotiated transactions. The 3.875% USD Notes due 2028 are fully and unconditionally guaranteed on a senior unsecured basis by generally all of the Company's domestic subsidiaries that guarantee the obligations of the borrowers under the Credit Agreement.

------

**Lines of Credit and Other Debt Facilities**

The Company has access to various revolving lines of credit, short-term debt facilities and overdraft facilities worldwide which are used to fund short-term cash needs. At March 31, 2026 the aggregate principal amount outstanding under such facilities totaled $85.0 million and there were no material amounts outstanding under such facilities at December 31, 2025. The Company had letters of credit outstanding of $7.0 million at each of March 31, 2026 and December 31, 2025, which reduced the borrowings available under the various facilities. At March 31, 2026 and December 31, 2025, the availability under these facilities, including the revolving credit facility under the Credit Agreement, totaled approximately $436 million and $390 million, respectively, net of outstanding letters of credit.

**7. FINANCIAL INSTRUMENTS**

**Derivatives and Hedging**

In the normal course of business, the Company is exposed to risks relating to changes in interest rates, foreign currency exchange rates and commodity prices. Derivative financial instruments, such as interest rate swaps, net investment hedges, foreign currency exchange forward contracts and commodities derivative contracts are used to manage the risks associated with changes in the conditions of those markets. The counterparties to the Company's derivative agreements are primarily major international financial institutions. The Company regularly monitors its derivative positions and the credit ratings of its counterparties and does not anticipate nonperformance on their part.

All derivatives are recognized in the Consolidated Balance Sheets at fair value. Realized gains and losses on foreign currency forward contracts, commodity derivative contracts and the net periodic payments from interest rate swaps and cross-currency swaps are reflected as "Cash flows from operating activities" in the Condensed Consolidated Statements of Cash Flows.

*Interest Rate and Cross-Currency Swaps*

The Company uses interest rate swaps and cross-currency swaps to reduce its exposure to interest rate risk and foreign currency risk. The Company has designated its interest rate swaps as cash flow hedges and its cross-currency swaps as net investment hedges of the foreign currency exposure of a portion of its net investment in euro functional subsidiaries. These swaps effectively convert the Company's outstanding term loans, which are U.S. dollar denominated debt obligations, into fixed-rate euro-denominated debt through their respective expiration dates.

In February 2026, the Company entered into new interest rate swaps and cross-currency swaps to effectively convert $350 million of the Add-on Term Loans, a U.S. dollar denominated debt obligation, into fixed-rate euro-denominated debt through December 2029.

The total notional value of the interest rate swaps and cross-currency swaps was $1.18 billion and $831 million at March 31, 2026 and December 31, 2025, respectively. As of March 31, 2026, approximately $694 million in notional value matures in December 2028 and approximately $485 million matures in December 2029. The remaining term loan notional value of approximately $108 million is not hedged. The net result of these hedges is an effective interest rate of approximately 4.5% at March 31, 2026 on the term loans B-3, which could vary in the future due to changes in the euro and the U.S. dollar exchange rate and, to a lesser extent, fluctuations in SOFR.

Changes in the estimated fair value of interest rate swaps are recorded in "Accumulated other comprehensive loss" and reclassified to "Interest expense, net" in the Condensed Consolidated Statements of Operations as the underlying hedged item affects earnings. The fair value of the interest rate swaps was a net liability of $3.4 million and $11.0 million at March 31, 2026 and December 31, 2025, respectively.

Changes in the estimated fair value of cross-currency swaps are recorded in "Foreign currency translation" in "Accumulated other comprehensive loss." The fair value of the cross-currency swaps was a net liability of $37.6 million and $64.7 million at March 31, 2026 and December 31, 2025, respectively.

------

For the three months ended March 31, 2026, these interest rate swaps and cross-currency swaps were deemed highly effective. The Company expects to reclassify $0.1 million of expense from "Accumulated other comprehensive loss" to "Interest expense, net" in the Condensed Consolidated Statements of Operations within the next twelve months.

*Foreign Currency*

The Company conducts a significant portion of its business in currencies other than the U.S. dollar and certain subsidiaries conduct business in currencies other than their functional currency, which is typically their local currency. As a result, the Company's operating results are impacted by foreign currency exchange rate volatility.

At March 31, 2026, the Company held foreign currency forward contracts to purchase and sell various currencies to mitigate foreign currency exposure primarily with the U.S. dollar, euro and British pound. The Company has not designated any foreign currency exchange forward contracts as eligible for hedge accounting and, as a result, changes in the fair value of foreign currency forward contracts are recorded in the Condensed Consolidated Statements of Operations as "Other expense, net." The total notional value of foreign currency exchange forward contracts held at March 31, 2026 and December 31, 2025 was approximately $203 million and $133 million, respectively, with settlement dates generally within one year. The fair value of the foreign currency forward contracts was a net current liability of $0.4 million and $0.9 million at March 31, 2026 and December 31, 2025, respectively.

*Commodities*

The Company enters into commodity derivative contracts for the purpose of mitigating its exposure to fluctuations in prices of certain metals used in the production of its finished goods. The Company held derivative contracts to purchase and sell various metals, primarily silver and tin, for a notional amount of $149 million and $91.4 million at March 31, 2026 and December 31, 2025, respectively. The fair value of the metals derivative contracts was a net current asset of $8.2 million and a net current liability of $13.5 million at March 31, 2026 and December 31, 2025, respectively. Substantially all contracts outstanding at March 31, 2026 have delivery dates within one year. The Company has not designated these derivatives as hedging instruments and, accordingly, records changes in their fair values in the Condensed Consolidated Statements of Operations as "Other expense, net."

------

**Fair Value Measurements**

The following table presents the Company's financial assets and liabilities measured at fair value on a recurring basis:

---

| | | | | |
|:---|:---|:---|:---|:---|
| *(dollars in millions)* | **Balance sheet location** | **Classification** | **March 31, 2026** | **December 31, 2025** |
| **Asset Category** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | Other current assets | Level 2 | $0.1 | $0.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Metals contracts | Other current assets | Level 2 | 8.8 | 1.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps | Other current assets | Level 2 | 0.7 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cross-currency swaps | Other current assets | Level 2 | 11.4 | 8.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps | Other assets | Level 2 | 0.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cross-currency swaps | Other assets | Level 2 | 4.2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** |  |  | $25.8 | $9.1 |
| **Liability Category** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange contracts | Accrued expenses and other current liabilities | Level 2 | $0.5 | $1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Metals contracts | Accrued expenses and other current liabilities | Level 2 | 0.6 | 14.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps | Accrued expenses and other current liabilities | Level 2 | 0.8 | 2.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swaps | Other liabilities | Level 2 | 3.9 | 8.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cross-currency swaps | Other liabilities | Level 2 | 53.2 | 72.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contingent consideration | Other liabilities | Level 3 | 22.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** |  |  | $81.0 | $99.2 |

---

The fair values of Level 2 derivative assets and liabilities are determined using pricing models based upon observable market inputs, such as market spot and futures prices on over-the-counter derivative instruments, market interest rates and consideration of counterparty credit risk.

The fair value of Level 3 contingent consideration represents a potential liability of up to $30.0 million cash or 1.16 million shares of the Company's common stock tied to EFC's expected achievement of Adjusted EBITDA performance metrics for fiscal year 2026. The fair value of the contingent consideration was derived using a Monte Carlo simulation model and the key assumptions included EFC's forecasted Adjusted EBITDA, expected volatility of the Company's stock price and the Company's stock price on the valuation date. From the closing date of the EFC Acquisition to March 31, 2026, the fair value of the contingent consideration increased by $5.9 million, which is recorded in "Selling, technical, general and administrative" in the Condensed Consolidated Statement of Operations.

There were no significant transfers of financial instruments between the fair value hierarchy levels for the three months ended March 31, 2026.

The carrying value and estimated fair value of the Company's long-term debt both totaled $2.07 billion at March 31, 2026. At December 31, 2025, the carrying value and estimated fair value both totaled $1.63 billion, respectively. The carrying values noted above include unamortized discounts and debt issuance costs. The estimated fair value of long-term debt is measured using quoted market prices for similar instruments at the reporting date multiplied by the gross carrying amount of the related debt, which excludes unamortized discounts and debt issuance costs. Such instruments are valued using Level 2 inputs.

------

**8. EARNINGS PER SHARE**

A computation of weighted average shares of the Company's common stock outstanding and earnings per share for the three months ended March 31, 2026 and 2025 is as follows:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31,** | **March 31,** |
| *(dollars in millions, except per share amounts)* | **2026** | **2025** |
| **Net income** | $56.0 | $98.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to non-controlling interests | (0.1) |  |
| **Net income attributable to common stockholders**  | $55.9 | $98.0 |
| **Basic weighted average common shares outstanding** | 243.2 | 242.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Denominator adjustments for diluted EPS: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Number of stock options and RSUs | 0.5 | 0.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Denominator adjustments for diluted EPS | 0.5 | 0.6 |
| **Diluted weighted average common shares outstanding** | 243.7 | 243.0 |
| **Earnings per share attributable to common stockholders:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.23 | $0.40 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.23 | $0.40 |

---

For the three months ended March 31, 2026 and 2025, the following securities were not included in the computation of diluted shares outstanding because either the effect would be anti-dilutive or the applicable performance targets were not yet met:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31,** | **March 31,** |
| *(shares in millions)* | **2026** | **2025** |
| Shares issuable for EFC contingent consideration | 1.2 |  |
| Shares issuable upon vesting of RSUs and exercise of stock options | 3.2 | 3.8 |
| &nbsp;&nbsp;&nbsp;&nbsp; **Total** | 4.4 | 3.8 |

---

**9. CONTINGENCIES, ENVIRONMENTAL AND LEGAL MATTERS**

*Environmental Matters*

The Company is involved in various claims relating to environmental matters at current and former plants and waste management sites. At certain of these sites, the Company engages or participates in remedial and other environmental compliance activities. At other sites, the Company has been named as a potential responsible party pursuant to the federal Superfund Act and/or state Superfund laws comparable to the federal law for site remediation. After analyzing each individual site, considering the number of parties involved, the level of its potential liability or contribution relating to the other parties, the nature and magnitude of the hazardous waste involved, the method and extent of remediation, the potential insurance coverage, the estimated legal and consulting expense with respect to each site and the time period over which any costs would likely be incurred, the Company estimates the clean-up costs and related claims for each site. The estimates are based in part on discussions with other potential responsible parties, governmental agencies and engineering firms.

The Company accrues for environmental matters when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current laws and existing technologies. The accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. The Company's environmental liabilities, which are included in the Condensed Consolidated Balance Sheets as "Accrued expenses and other current liabilities" and "Other liabilities," totaled $10.5 million and $9.6 million at March 31, 2026 and December 31, 2025, respectively, primarily driven by environmental remediation, clean-up costs and monitoring of sites that were either closed or

------

disposed of in prior years. While uncertainty exists with respect to the amount and timing of its ultimate environmental liabilities, the Company does not currently anticipate any material losses in excess of the amount recorded. However, new information about the sites, such as results of investigations, could make it necessary for the Company to reassess its potential exposure related to these environmental matters.

As of the date hereof, the Company believes it is not practicable to provide an estimated range of reasonably possible environmental losses in excess of its recorded liabilities. As a result, the Company is unable to ascertain the ultimate aggregate amount of monetary liability or financial impact that may be associated with these matters.

*Legal Matters*

From time to time, the Company is involved in various legal proceedings, investigations and/or claims in the normal course of its business. Although it cannot predict with certainty the ultimate resolution of these matters, which involve judgments that are inherently subjective, the Company believes that their resolutions, to the extent not covered by insurance, will not, individually or in the aggregate, have a material adverse effect on its consolidated financial position, results of operations or cash flows.

**10. INCOME TAXES**

The Company's quarterly income tax provision is measured using an estimate of its consolidated annual effective tax rate, which includes the impact of foreign withholding tax accruals and uncertain tax positions, adjusted for discrete items, within the periods presented. The comparison of the Company's income tax provision between periods can be significantly impacted by the level and mix of earnings, losses by tax jurisdiction and discrete items.

For the three months ended March 31, 2026, the Company recognized income tax expense of $26.7 million as compared to $17.8 million in the same period for 2025. Income tax expense for the three months ended March 31, 2026, includes a continued U.S. benefit related to claiming foreign tax credits, a recurring benefit from a U.S. tax deduction related to foreign-derived deduction eligible income (commonly referred to as FDDEI) partially offset with foreign tax credit valuation allowances of $6.4 million and net Controlled Foreign Corporation tested income (commonly referred to as NCTI) including the impact of changes to the level and mix of earnings. The foreign tax credit valuation allowance was required after taking into account the impacts on projected future taxable income from the EFC and Micromax Acquisitions, including significant tax-basis amortization of acquired intangible property and increased interest expense from the Add-on Term Loans.

Income tax expense for the three months ended March 31, 2025, included a continued U.S. benefit related to claiming foreign tax credits and a benefit from a U.S. tax deduction related to foreign-derived intangible income (commonly referred to as FDII), partially offset by a $7.7 million multi-year tax settlement and the impact of changes to the level and mix of earnings.

On February 28, 2025, the Company completed the MGS Transaction and realized a gain on sale of $72.1 million as of March 31, 2025. This transaction resulted in a nominal tax impact which reduced the effective tax rate primarily due to the realization of a deferred tax asset and an offsetting release of a valuation allowance.

**11. RELATED PARTY TRANSACTIONS**

The Company is party to an Advisory Services Agreement with Mariposa Capital, LLC, an affiliate of one of its founder directors, whereby Mariposa Capital, LLC is entitled to receive an annual fee of $2.0 million and reimbursement for expenses, which are recorded in the Condensed Consolidated Statements of Operations as "Selling, technical, general and administrative" expense. This agreement is automatically renewed for successive one-year terms unless either party notifies the other in writing of its intention not to renew no later than 90 days prior to the expiration of the applicable term.

**12. SEGMENT INFORMATION**

The Company's operations are organized into two reportable segments: Electronics and Specialties. These segments represent businesses for which separate financial information is utilized by the chief operating decision maker (CODM) for purposes of allocating resources and evaluating performance. The Company's CODM is the Chief Executive Officer.

------

The CODM utilizes net sales and Adjusted EBITDA to allocate resources predominantly in the annual budget and forecasting process. The CODM evaluates the performance of the operating segments by considering budget to actual variances when making decisions about allocating capital and personnel to the segments and determining the compensation of certain employees. Adjusted EBITDA for each segment is defined as EBITDA, as further adjusted for additional items included in earnings which the Company believes are not representative or indicative of each of its segments' ongoing business or are considered to be associated with the Company's capital structure. Adjusted EBITDA for each segment also includes an allocation of corporate costs, such as compensation expense and professional fees.

**Disaggregated Net Sales**

The following table summarizes disaggregated external net sales by product category:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31,** | **March 31,** |
| *(dollars in millions)* | **2026** | **2025** |
| **Net sales:** |  |  |
| **Electronics** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Assembly Solutions | $325.5 | $194.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Circuitry Solutions | 145.6 | 120.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Micromax | 64.8 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Semiconductor Solutions | 97.6 | 80.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;**&nbsp;&nbsp;&nbsp;&nbsp; Total Electronics** | 633.5 | 394.3 |
| **Specialties** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrial Solutions | 166.0 | 157.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;EFC | 18.6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Graphics Solutions |  | 24.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy Solutions | 21.9 | 18.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Specialties** | 206.5 | 199.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total net sales** | $840.0 | $593.7 |

---

------

**Results of Operations**

The following table reconciles "Net income" to Adjusted EBITDA:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31,** | **March 31,** |
| *(dollars in millions)* | **2026** | **2025** |
| **Net income** | $56.0 | $98.0 |
| *Add (subtract):* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax expense | 26.7 | 17.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 21.5 | 14.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation expense | 14.5 | 10.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization expense | 28.0 | 27.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**EBITDA** | 146.7 | 167.3 |
| *Adjustments to reconcile to Adjusted EBITDA:* |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory step-up | 3.4 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring expense | 1.8 | 1.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition, integration and transaction expenses | 20.1 | 8.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange losses on intercompany loans | 0.9 | 6.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures |  | (72.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Unrealized (gains) losses on metals derivative contracts | (21.7) | 10.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt financing costs |  | 1.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of EFC contingent consideration | 5.9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 5.2 | 5.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted EBITDA** | $162.3 | $128.4 |

---

The following tables summarize financial information regarding each reportable segment's results of operations. As noted above, Adjusted EBITDA for each segment excludes certain items that may not be indicative of the Company's core operating results for its reportable segments. As such, the "Segment Total" below may not agree to the corresponding amounts on the Condensed Consolidated Statements of Operations.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
| *(dollars in millions)* | **Electronics** | **Specialties** | **Segment Total** | **Electronics** | **Specialties** | **Segment Total** |
| **Net sales** | $633.5 | $206.5 | $840.0 | $394.3 | $199.4 | $593.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 401.0 | 109.5 | 510.5 | 233.2 | 109.7 | 342.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, technical, general and administrative | 80.5 | 55.6 | 136.1 | 65.3 | 51.9 | 117.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 15.5 | 3.5 | 19.0 | 12.0 | 3.3 | 15.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other segment items <sup>(1)</sup> | 27.0 | (0.4) | 26.6 | 0.7 | (0.8) | (0.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Add: Depreciation expense | 9.6 | 4.9 | 14.5 | 5.8 | 4.2 | 10.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted EBITDA** | $119.1 | $43.2 | $162.3 | $88.9 | $39.5 | $128.4 |

---

<sup>(1)</sup> *Other segment items for the Electronics segment primarily consisted of $26.7 million and $0.3 million of realized losses associated with metals derivative contracts for the three months ended March 31, 2026 and 2025, respectively. See Note 7, Financial Instruments, to the Condensed Consolidated Financial Statements for further discussion of these derivative instruments.*

------

**Assets by Reportable Segment**

Total assets by reportable segment at March 31, 2026 and December 31, 2025 are not presented as they are not utilized for purposes of allocating resources and evaluating performance.

------

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

*This Management's Discussion and Analysis of Financial Condition and Results of Operations section should be read in conjunction with the unaudited Condensed Consolidated Financial Statements and related notes included in this Quarterly Report, and the Consolidated Financial Statements, related notes and Management's Discussion and Analysis of Financial Condition and Results of Operations section and other disclosures contained in our 2025 Annual Report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements as a result of several factors, including, but not limited to, those discussed in "Forward-Looking Statements" of this Quarterly Report, and in Part I, Item 1A, "Risk Factors" of our 2025 Annual Report.*

***Overview***

*Our Business*

Element Solutions, incorporated in Delaware in January 2014, is a leading global specialty chemicals technology company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. Developed in multi-step technological processes, these innovative solutions enable customers' manufacturing processes in multiple high-value industries, including semiconductor fabrication, high-performance computing, automotive systems, consumer electronics, power electronics, communications and data storage infrastructure, aerospace and defense, industrial surface finishing and offshore energy. Our product innovation and product extensions are expected to continue to drive sales growth in both new and existing markets while expanding margins through a consistent focus on increasing customer value propositions.

We believe the majority of our businesses hold strong positions in the high-growth markets we serve. Our extensive global teams of specially trained scientists and engineers develop our solutions, and our expert sales and service organizations ensure our customers' needs are met every day. Our customer-centric innovation means we develop technologies to meet the identified needs of our supply chains. We solve our customers' existing and emerging problems through technical service and innovation. We believe that our customers place significant value on the consistency and quality of our brands, on which we capitalize through significant market share, customer loyalty and supply chain access. In addition, operational risks and switching costs make it difficult for our customers to change suppliers which allows us to retain customers and maintain our market positions.

Our customers rely on our innovation to develop new products of their own, so our capabilities help them keep up in fast-paced, high-growth markets. To that end, we draw upon our broad and longstanding intellectual property portfolio and technical expertise, while working closely with both customers and OEMs on an ongoing basis, to develop proprietary solutions tailored to their manufacturing needs. We leverage these close relationships to win qualifications and specifications into their supply chains as well as to identify opportunities for new products; all of which provide potential additional revenue streams.

Our strategy is based on a balance of operational excellence and prudent capital allocation. Our operating teams focus on the strong execution of customer-led product development, superior technical sales support and continuous supply chain optimization. Our senior leadership aims to foster an environment of accountability and success for our operating teams while also evaluating and executing on high-return capital allocation opportunities that can drive compounding of long-term intrinsic value per share.

*Our Operations*

Our operations are organized into two segments: Electronics and Specialties, which are each described below:

***Electronics*** – Our Electronics segment researches, formulates and sells specialty chemicals and material process technologies for all types of electronics hardware, from complex printed circuit board designs to advanced semiconductor packaging. In high-performance datacenters, mobile communications, computers, automobiles and aerospace equipment, its products are an integral part of the electronics manufacturing process and the functionality of end-products. The segment's "wet chemistries" for metallization, surface treatments and solderable finishes form the physical circuitry pathways and its "assembly materials," such as SMT, pastes, fluxes and adhesives, join those pathways together.

------

Electronics provides solutions through the following businesses:

---

| | |
|:---|:---|
| *Assembly Solutions* | As a global supplier of SMT, fluxes, thermal management materials, coatings and other attachment materials, we develop high-performing innovative materials that are used to assemble consumer electronics from circuit boards, discrete electronic components, connectors and integrated circuit substrates. We believe our growth in this business will be driven by the increasing use of electronics in consumer, automotive, telecommunications, memory, medical, aerospace and other markets. |
| *Circuitry Solutions* | As a global supplier of chemical formulations to the electronics industry, we design and manufacture proprietary "wet" chemical processes and materials used by our customers to manufacture printed circuit boards and memory storage devices. Our product portfolio is focused on specialized consumable chemical processes and materials, such as circuit formation, primary metallization, electroplate, surface finishes and flexible/formable films. We believe our growth in this business will be driven by demand in wireless mobile devices, internet infrastructure, high performance computing, and the increasing use of electronics in automobiles. |
| *Micromax* | As a global supplier of conductive, resistive and dielectric thick film pastes for passive components, low temperature co-fired ceramics (LTCC) for multilayer circuit integration, and electronics inks for printed electronics, we provide high-reliability microcircuit solutions for a variety of high-cost-of-failure applications. We believe our growth in this business will be driven by increased passive component density in datacenter and automotive electronics, as well as demand for more advanced radar and communication solutions and health & safety technologies.  |
| *Semiconductor Solutions* | As a global supplier to the semiconductor industry, we provide advanced copper interconnects, die attachment, sintered silver material, adhesives, wafer bump processes and photomask technologies to our customers for integrated circuit fabrication and semiconductor packaging. We believe our growth in this business will be driven by advanced electronics packaging, necessary to meet the growing needs of high performance computing, artificial intelligence, the internet of things, next-generation wireless communications and the increasing content and complexity of electronics in automotive applications. |

---

***Specialties*** – Our Specialties segment researches, formulates and sells specialty chemicals and material process technologies that enable or enhance the performance of high value products across diverse sectors from automotive to energy infrastructure to semiconductors and satellites. Its products include chemical systems that protect and decorate metal and plastic surfaces, chemistries used in water-based hydraulic control fluids for offshore energy production and rare or high-purity gases and advanced materials used in semiconductor fabrication, satellite systems, electrical transmission infrastructure and other end-markets.

Specialties provides solutions through the following businesses:

---

| | |
|:---|:---|
| *Industrial Solutions* | As a global supplier of industrial metal and plastic finishing chemistries, we primarily design and manufacture chemical systems that protect and decorate surfaces. Our high-performance functional coatings improve resistance to wear and tear, such as chrome plating of shock absorbers for cars, or provide corrosion resistance for appliance parts. Our decorative performance coatings apply finishes for parts in various end markets, such as automotive interiors or jewelry surfaces. Our industrial customer base is highly diverse and includes customers in the following end markets: appliances and electronics equipment; automotive parts; industrial parts; plumbing goods; construction equipment and transportation equipment. In this business, we also sell certain water-treatment solutions and lubricants used in similar end-markets. We believe our growth in this industry will be primarily driven by increased worldwide automobile production with elevated fashion elements and higher content per vehicle as well as general economic growth. |
| *EFC* | As a global supplier of high purity electronic gases, rare gases and advanced materials, we provide specialized solutions, including tailored gas recovery, filling and recycling systems, to a range of fast-growing and highly complex industries, including semiconductor manufacturing, aerospace and electrical infrastructure. We believe our growth in this business will be driven by gas molecule qualifications at semiconductor fabricators, growth in satellite launches and increased investment in domestic electrical transmission infrastructure. |
| *Energy Solutions* | As a global supplier of specialized fluids to the offshore energy industry, we produce water-based hydraulic control fluids for major oil and gas companies and drilling contractors to be used in offshore deep-water production and drilling applications. We believe our growth in this business will be driven by continued capital expenditures in energy exploration and production. |

---

------

***Recent Developments***

*Micromax Acquisition* - On February 2, 2026, we completed the acquisition of Micromax, a global supplier of advanced electronics inks and pastes, for a purchase price of approximately $493 million, net of cash and subject to adjustments.

*EFC Acquisition* - On January 2, 2026, we completed the acquisition of EFC, a provider of high-purity specialty gases and other advanced materials, for a purchase price of approximately $367 million, net of cash and subject to adjustments, with a potential earn-out based on EFC's 2026 performance of up to $30.0 million cash or 1.16 million shares of the Company's common stock.

*Add-on Term Loans & Revolver Upsize* - On February 2, 2026, we completed the syndication of $450 million of Add-on Term Loans and a 5-year $500 million senior secured revolving credit facility, which replaced our then existing $375 million revolving facility, upsizing the facility by $125 million and extending its maturity to 2031. The proceeds of the Add-on Term Loans were used to fund a portion of the purchase price of the Micromax Acquisition.

***Recent Accounting Pronouncements***

Our recent accounting pronouncements have not changed materially from the summary disclosed in Note 3, *Recent Accounting Pronouncements*, to the Consolidated Financial Statements included in our 2025 Annual Report.

***Non-GAAP Financial Measures***

To supplement our financial results presented in accordance with GAAP in this Management's Discussion and Analysis of Financial Condition and Results of Operations section, we present certain non-GAAP financial measures, such as operating results on a constant currency and organic basis, Adjusted EBITDA and Adjusted EBITDA margin. Management internally reviews these non-GAAP measures to evaluate performance on a comparative period-to-period basis in terms of absolute performance, trends and expected future performance with respect to our business. We believe these non-GAAP financial measures, which are each further described below, provide investors with an additional perspective on trends and underlying operating results on a period-to-period comparable basis. We also believe that investors find this information helpful in understanding the ongoing performance of our operations separate from items that may have a disproportionate positive or negative impact on our financial results in any particular period or are considered to be associated with our capital structure.

These non-GAAP financial measures, however, have limitations as analytical tools and should not be considered in isolation from, a substitute for, or superior to, the related financial information that we report in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in our financial statements and may not be completely comparable to similarly titled measures of other companies due to potential differences in calculation methods. In addition, these measures are subject to inherent limitations as they reflect the exercise of judgment by management about which items are excluded or included in determining these non-GAAP financial measures. Investors are encouraged to review the definitions and reconciliations of these non-GAAP financial measures to their most comparable GAAP financial measures included in this Quarterly Report and not to rely on any single financial measure to evaluate our business.

**Constant Currency**

We disclose certain financial measures and Adjusted EBITDA, on a constant currency basis by adjusting results to exclude the impact of changes due to the translation of foreign currencies of our international locations into U.S. dollars. Management believes this non-GAAP financial information facilitates period-to-period comparison in the analysis of trends in business performance, thereby providing valuable supplemental information regarding our results of operations, consistent with how we internally evaluate our financial results.

The impact of foreign currency translation is calculated by converting our current-period local currency financial results into U.S. dollars using the prior period's exchange rates and comparing these adjusted amounts to our prior period reported results. The difference between actual growth rates and constant currency growth rates represents the estimated impact of foreign currency translation.

------

**Organic Net Sales Growth**

Organic net sales growth is defined as net sales excluding the impact of foreign currency translation, changes due to the pass-through pricing of certain metals and acquisitions and/or divestitures, as applicable. Management believes this non-GAAP financial measure provides investors with a more complete understanding of the underlying net sales trends by providing comparable net sales over differing periods on a consistent basis.

For a reconciliation of GAAP net sales growth to organic net sales growth, see "*Net Sales*" within the "Results of Operations" section below.

**Adjusted EBITDA and Adjusted EBITDA Margin**

We define Adjusted EBITDA as EBITDA, excluding the impact of additional items included in GAAP earnings which we believe are not representative or indicative of our ongoing business or are considered to be associated with our capital structure. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net sales excluding the value of certain pass-through metals in the Electronics segment. Adjusted EBITDA margin excludes the impact of certain pass-through metals in the Electronics segment as we believe the fluctuations in these metal prices do not reflect underlying operating results. Management believes Adjusted EBITDA and Adjusted EBITDA margin provide investors with a more complete understanding of the long-term profitability trends of our business and facilitates comparisons of our profitability to prior and future periods.

For a reconciliation of "Net income" to Adjusted EBITDA and more information about the adjustments made, see Note 12, *Segment Information*, to the unaudited Condensed Consolidated Financial Statements included in this Quarterly Report.

------

**Results of Operations**

***Three months ended March 31, 2026 compared to three months ended March 31, 2025***

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **% Change** | **% Change** | **% Change** |
| | **March 31,** | **March 31,** | **% Change** | **% Change** | **% Change** |
| *(dollars in millions)* | **2026** | **2025** | **Reported** | **Constant Currency** | **Organic** |
| **Net sales** | $840.0 | $593.7 | 41% | 37% | 10% |
| Cost of sales | 517.3 | 343.2 | 51% | 46% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Gross profit** | 322.7 | 250.5 | 29% | 25% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*Gross margin* | *38.4%* | *42.2%* | *(380) bps* | *(380) bps* |  |
| Operating expenses | 211.3 | 173.1 | 22% | 19% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Operating profit** | 111.4 | 77.4 | 44% | 38% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*Operating margin* | *13.3%* | *13.0%* | *30bps* | *10bps* |  |
| Other (expense) income, net | (28.7) | 38.4 | (nm) |  |  |
| Income tax expense | (26.7) | (17.8) | 51% |  |  |
| &nbsp;&nbsp;**Net income** | $56.0 | $98.0 | (43)% |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;*Net income margin* | *6.7%* | *16.5%* | *(980)bps* |  |  |
| **Adjusted EBITDA** | $162.3 | $128.4 | 26% | 21% |  |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA margin* | *27.8%* | *26.1%* | *170bps* |  |  |

---

*(nm) Calculation not meaningful.*

------

***Net Sales***

Net sales in the first quarter of 2026 increased 41% on a reported basis and 10% on an organic basis. Electronics' consolidated results were positively impacted by $101 million of pass-through metals pricing and $64.8 million of acquisitions and Specialties' consolidated results were negatively impacted by $5.6 million of divestitures net of acquisitions.

The following table reconciles GAAP net sales growth to organic net sales growth:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **% Change** | **% Change** | **% Change** | **% Change** | **% Change** |
| | **March 31,** | **March 31,** | **% Change** | **% Change** | **% Change** | **% Change** | **% Change** |
| *(dollars in millions)* | **2026** | **2025** | **Reported Net Sales Growth** | **Impact of Currency** | **Pass-Through Metals Pricing** | **Acquisitions & Divestitures** | **Organic Net Sales Growth** |
| **Electronics:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Assembly Solutions | $325.5 | $194.1 | 68% | (4)% | (52)% | —% | 12% |
| &nbsp;&nbsp;&nbsp;&nbsp;Circuitry Solutions | 145.6 | 120.1 | 21% | (4)% | —% | —% | 17% |
| &nbsp;&nbsp;&nbsp;&nbsp;Micromax | 64.8 |  | 100% | —% | —% | (100)% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Semiconductor Solutions | 97.6 | 80.1 | 22% | (3)% | —% | —% | 18% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 633.5 | 394.3 | 61% | (4)% | (26)% | (16)% | 15% |
| **Specialties:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Industrial Solutions | 166.0 | 157.2 | 6% | (6)% | —% | —% | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;EFC | 18.6 |  | 100% | —% | —% | (100)% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Graphics Solutions |  | 24.2 | (100)% | —% | —% | 100% | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;Energy Solutions | 21.9 | 18.0 | 21% | (6)% | —% | —% | 15% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 206.5 | 199.4 | 4% | (5)% | —% | 3% | 1% |
| **Total** | $840.0 | $593.7 | 41% | (4)% | (17)% | (10)% | 10% |

---

*NOTE: Totals may not sum due to rounding.*

Electronics' net sales in the first quarter of 2026 increased 61% on a reported basis and 15% on an organic basis. Net sales from pass-through metals were $256 million and $101 million for the three months ended March 31, 2026 and 2025, respectively.

• <u>Assembly Solutions:</u> net sales increased 68% on a reported basis and 12% on an organic basis. Pass-through metals pricing had a positive impact of 52% on reported net sales. Foreign exchange had a positive impact of 4% on reported net sales. The increase in organic net sales was primarily due to demand for engineered preform materials in datacenter applications and strength in pastes for premium smartphones in Asia.

• <u>Circuitry Solutions:</u> net sales increased 21% on a reported basis and 17% on an organic basis. Foreign exchange had a positive impact of 4% on reported net sales. The increase in organic net sales was primarily due to continued AI and data center investment driving demand for metallization solutions.

• <u>Micromax:</u> The Company completed the Micromax Acquisition on February 2, 2026. See Note 2, *Acquisitions,* to the unaudited Condensed Consolidated Financial Statements for further information.

• <u>Semiconductor Solutions:</u> net sales increased 22% on a reported basis and 18% on an organic basis. Foreign exchange had a positive impact of 3% on reported net sales. The increase in organic net sales was primarily due to increased demand in Asia for plating solutions for advanced packaging and inflation on precious metals content within these products, as well as growth in power electronics.

Specialties' net sales in the first quarter of 2026 increased 4% on a reported basis and 1% on an organic basis.

• <u>Industrial Solutions:</u> net sales increased 6% on a reported basis and were relatively flat on an organic basis. Foreign exchange had a positive impact of 6% on reported net sales. Flat organic sales were the result of automotive customer softness in the Americas offset by the impact of higher metal surcharges.

------

• <u>EFC:</u> The Company completed the EFC Acquisition on January 2, 2026. See Note 2, *Acquisitions,* to the unaudited Condensed Consolidated Financial Statements for further information.

• <u>Energy Solutions:</u> net sales increased 21% on a reported basis and 15% on an organic basis. Foreign exchange had a positive impact of 6% on reported net sales. The increase in organic net sales was primarily due to pricing actions and an increase in production volumes from competitive wins.

***Gross Profit***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **% Change** | **% Change** |
| | **March 31,** | **March 31,** | **% Change** | **% Change** |
| *(dollars in millions)* | **2026** | **2025** | **Reported** | **Constant Currency** |
| **Gross profit** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Electronics | $228.7 | $161.0 | 42% | 39% |
| &nbsp;&nbsp;&nbsp;&nbsp;Specialties | 94.0 | 89.5 | 5% | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $322.7 | $250.5 | 29% | 25% |
| **Gross margin** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Electronics | 36.1% | 40.8% | (470) bps |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Specialties | 45.5% | 44.8% | 70 bps |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | 38.4% | 42.2% | (380) bps |  |

---

Electronics' gross profit in the first quarter of 2026 increased by 42% on a reported basis and 39% on a constant currency basis. The Micromax Acquisition had a positive impact of 8% on constant currency gross profit which includes $13.6 million of gross profit less an inventory step-up from purchase accounting of $1.4 million. The constant currency increase in gross profit dollars was primarily driven by broad-based organic volume growth across the Electronics businesses. Gross profit margins excluding net sales from pass-through metals improved 550 bps when compared to the first quarter of 2025. The increase in gross margin excluding the impact of pass-through metals was primarily due to positive mix from higher value product sales within the portfolio, including the Micromax products.

Specialties' gross profit in the first quarter of 2026 increased by 5% on a reported basis and remained relatively flat on a constant currency basis. The EFC Acquisition had a positive impact of 7% on constant currency gross profit which includes $7.9 million of gross profit less an inventory step-up from purchase accounting of $2.0 million. The MGS Transaction had a negative impact of $8.8 million, or 10%, on constant currency gross profit. Underlying gross margin improvement was primarily driven by growth in the higher margin Energy Solutions business.

***Operating Expenses***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **% Change** | **% Change** |
| | **March 31,** | **March 31,** | **% Change** | **% Change** |
| *(dollars in millions)* | **2026** | **2025** | **Reported** | **Constant Currency** |
| Selling, technical, general and administrative | $191.1 | $157.2 | 22% | 19% |
| Research and development | 20.2 | 15.9 | 27% | 25% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $211.3 | $173.1 | 22% | 19% |

---

Operating expenses in the first quarter of 2026 increased 22% on a reported basis and 19% on a constant currency basis. The constant currency increase was primarily driven by $10.3 million of operating expenses related to businesses acquired in the first quarter of 2026 ($5.5 million from the Micromax Acquisition and $4.8 million from the EFC Acquisition), $10.3 million of higher non-recurring acquisition costs, higher incentive compensation costs due to increased expectations for strong full year financial results and a $5.9 million increase in the fair value of the contingent consideration associated with the EFC Acquisition in the first quarter of 2026; partially offset by $4.5 million of lower operating expenses due to the sale of MacDermid Graphics Solutions in the first quarter of 2025.

------

***Other (Expense) Income***

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31,** | **March 31,** |
| *(dollars in millions)* | **2026** | **2025** |
| **Other (expense) income** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | $(21.5) | $(14.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign exchange losses | (0.9) | (6.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense, net | (6.3) | (13.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on divestitures |  | 72.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $(28.7) | $38.4 |

---

*Interest expense, net*

For the three months ended March 31, 2026 and 2025, interest expense, net increased $7.2 million primarily due to a higher effective interest rate on a higher outstanding term loan principal balance and lower interest income when compared to the prior year period as well as interest expense borrowings under the Company's revolving credit facility in the first quarter of 2026.

*Foreign exchange losses* 

For the three months ended March 31, 2026 and 2025, the fluctuations in foreign exchange losses were primarily driven by the remeasurement of intercompany loans.

*Other expense, net*

For the three months ended March 31, 2026, other expense, net included $5.2 million of net losses associated with metals derivative contracts ($26.9 million of realized losses and $21.7 million of unrealized gains) and $0.6 million of charges due to highly inflationary accounting for our operations in Turkey. For the three months ended March 31, 2025, other expense, net included $11.1 million of net losses associated with metals derivative contracts ($0.3 million of realized and $10.8 million of unrealized losses), $1.8 million of debt extinguishment costs related to the partial prepayment of our term loans B-3 and $1.2 million of charges due to highly inflationary accounting for our operations in Turkey.

The metal derivative contracts primarily relate to inventory associated with pass-through metals pricing in our Assembly Solutions business and are intended to mitigate the impact on "Gross profit" associated with fixed price agreements with our customers or commodity price movement after inventory is purchased. See Note 7, *Financial Instruments,* to the unaudited Condensed Consolidated Financial Statements for further discussion of these derivative instruments.

*Gain on divestitures*

In the first quarter of 2025, we completed the sale of our flexographic printing plate business, MacDermid Graphics Solutions, resulting in a gain of $72.1 million.

***Income Tax***

For the three months ended March 31, 2026, the Company recognized income tax expense of $26.7 million as compared to $17.8 million in the same period for 2025. Income tax expense for the three months ended March 31, 2026, includes a continued U.S. benefit related to claiming foreign tax credits, a recurring benefit from a U.S. tax deduction related to foreign-derived deduction eligible income (commonly referred to as FDDEI) partially offset with foreign tax credit valuation allowances of $6.4 million and net Controlled Foreign Corporation tested income (commonly referred to as NCTI) including the impact of changes to the level and mix of earnings. The foreign tax credit valuation allowance was required after taking into account the impacts on projected future taxable income from the EFC and Micromax Acquisitions, including significant tax-basis amortization of acquired intangible property and increased interest expense from the Add-on Term Loans.

------

Income tax expense for the three months ended March 31, 2025, included a continued U.S. benefit related to claiming foreign tax credits and a benefit from a U.S. tax deduction related to foreign-derived intangible income (commonly referred to as FDII), partially offset by a $7.7 million multi-year tax settlement and the impact of changes to the level and mix of earnings.

On February 28, 2025, we completed the MGS Transaction and realized a gain on sale of $72.1 million as of March 31, 2025. This transaction resulted in a nominal tax impact which reduced the effective tax rate primarily due to the realization of a deferred tax asset and an offsetting release of a valuation allowance.

See Note 10, *Income Taxes*, to the unaudited Condensed Consolidated Financial Statements for further information.

***Segment Adjusted EBITDA Performance***

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **% Change** | **% Change** |
| | **March 31,** | **March 31,** | **% Change** | **% Change** |
| *(dollars in millions)* | **2026** | **2025** | **Reported** | **Constant Currency** |
| **Net income:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $56.0 | $98.0 | (43)% |  |
| **Adjusted EBITDA:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Electronics | $119.1 | $88.9 | 34% | 29% |
| &nbsp;&nbsp;&nbsp;&nbsp;Specialties | 43.2 | 39.5 | 9% | 3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | $162.3 | $128.4 | 26% | 21% |
| **Net income margin:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | 6.7% | 16.5% | (980) bps |  |
| **Adjusted EBITDA margin:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Electronics | 31.5% | 30.3% | 120bps |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Specialties | 20.9% | 19.8% | 110bps |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | 27.8% | 26.1% | 170bps |  |

---

For the three months ended March 31, 2026, Electronics' Adjusted EBITDA increased 34% on a reported basis and 29% on a constant currency basis. The Micromax Acquisition had a positive impact of $10.2 million, or 11%, on constant currency Adjusted EBITDA. The remaining constant currency increase was primarily driven by the broad-based increase in sales across all businesses.

Specialties' Adjusted EBITDA increased 9% on a reported basis and 3% on a constant currency basis. The EFC Acquisition had a positive impact of $3.7 million, or 9%, on constant currency Adjusted EBITDA. The MGS Transaction had a negative impact of $5.3 million, or 13%, on constant currency Adjusted EBITDA. The remaining constant currency increase was primarily driven by growth from the Energy Solutions business.

**Liquidity and Capital Resources** 

Our primary sources of liquidity during the three months ended March 31, 2026 were the proceeds from the Add-on Term Loans and our revolving credit facility and available cash generated from operations. Our primary uses of cash and cash equivalents were to fund the Micromax Acquisition, the EFC Acquisition and operations, including working capital and capital expenditures and pay cash dividends. Our first significant debt principal payment of approximately $800 million is related to the maturity of our 3.875% USD Notes due 2028. In the first quarter of 2026, we paid a cash dividend of 8 cents per share. We currently expect to continue to pay a cash dividend on a quarterly basis; however, the actual declaration of any cash dividends as well as their amounts and timing, will be subject to the final determination of our Board of Directors based on factors including our future earnings and cash flow generation.

------

For the full year 2026, we expect our capital expenditures to be approximately $75.0 million to $100 million. We believe that our cash and cash equivalents and cash generated from operations, supplemented by our availability under our lines of credit, including our revolving credit facility under the Credit Agreement, will be sufficient to meet our working capital needs, interest payments, capital expenditures, potential dividend payments and other business requirements for at least the next twelve months. However, working capital cycles and/or future repurchases of our common stock and/or acquisitions may require additional funding, which may include future debt and/or equity offerings. Our long-term liquidity may be influenced by our ability to borrow additional funds, manage interest rates, renegotiate existing debt and/or raise new equity or debt under terms that are favorable to us.

We may from time to time seek to repurchase our equity and/or to retire or repurchase our outstanding debt through cash purchases and/or exchanges for equity, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions, applicable restrictions under our various financing arrangements and other factors.

During the three months ended March 31, 2026, approximately 76% of our net sales were generated from non-U.S. operations, and we expect a large portion of our net sales to continue to be generated outside of the U.S. As a result, our foreign subsidiaries will likely continue to generate a substantial portion of our cash. We manage our worldwide cash requirements with available funds generated by the many subsidiaries through which we conduct business. We expect to continue to have cost efficient access to those funds on a global basis. We may transfer cash from certain international subsidiaries to the U.S. and/or other international subsidiaries when we believe it is cost effective to do so. Of our $177 million of cash and cash equivalents at March 31, 2026, $145 million was held by our foreign subsidiaries.

The following is a summary of our cash flows (used in) provided by operating, investing, and financing activities during the periods indicated:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** |
| | **March 31,** | **March 31,** |
| *(dollars in millions)* | **2026** | **2025** |
| Cash (used in) provided by operating activities | $(66.6) | $26.0 |
| Cash (used in) provided by investing activities | $(889.3) | $337.6 |
| Cash provided by (used in) financing activities | $507.8 | $(227.3) |

---

***Operating Activities***

The decrease in net cash flows provided by operating activities of $92.6 million was primarily driven by higher investment in working capital from rising metals prices partially offset by higher cash operating profits (net income adjusted for non-cash items), including higher earnings as a result of the Micromax Acquisition and the EFC Acquisition, and lower incentive compensation due to timing of payments associated with 2025 performance.

***Investing Activities***

During the three months ended March 31, 2026, we paid $493 million in connection with the Micromax Acquisition and $367 million in connection with the EFC Acquisition. During the three months ended March 31, 2025, we received cash proceeds of $323 million upon the closing of the MGS Transaction.

***Financing Activities***

During the three months ended March 31, 2026, we received cash proceeds of $449 million from the Add-on Term Loans and $85.0 million in net borrowings from the revolving credit facility. In addition, we paid $20.2 million of cash dividends on shares of our common stock. During the three months ended March 31, 2025, we prepaid $200 million of our term loans B-3 and paid $19.8 million of cash dividends on shares of our common stock and $4.8 million for shares of our common stock withheld to satisfy the tax withholding requirements related to the vesting of RSUs included in "Other, net."

------

**Financial Borrowings**

***Credit Facilities and Senior Notes***

At March 31, 2026, we had $2.16 billion of indebtedness, net of unamortized discounts and debt issuance costs of $14.6 million, which was comprised of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $1.29 billion of term debt arrangements outstanding under our term loans;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $800 million of 3.875% USD Notes due 2028; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• $85.0 million outstanding under our revolving credit facility.

Availability under our revolving credit facility and various lines of credit and overdraft facilities totaled $436 million at March 31, 2026 (net of $7.0 million of stand-by letters of credit which reduce our borrowing capacity).

***Covenants***

At March 31, 2026, we were in compliance with the debt covenants contained in the Credit Agreement and the indenture governing our 3.875% USD Notes due 2028.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk**

The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our 2025 Annual Report. For a discussion of our exposure to market risk, refer to Part II, Item 7A, *Quantitative and Qualitative Disclosures about Market Risk*, contained in our 2025 Annual Report.

**Item 4. Controls and Procedures**

**(a) Evaluation of Disclosure Controls and Procedures**

Based on management's evaluation (with the participation of our CEO and CFO), as of the end of the period covered by this Quarterly Report, our CEO and CFO have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are effective to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms, and is accumulated and communicated to management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

**(b) Changes to Internal Control Over Financial Reporting**

Based on management's evaluation (with the participation of our CEO and CFO), there have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter covered by this Quarterly Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings**

From time to time, we are involved in legal proceedings, investigations and/or claims that are incidental to the operation of our businesses. In particular, we are involved in various claims relating to environmental matters at a number of current and former plant sites and waste management sites. See Note 9, *Contingencies, Environmental and Legal Matters*, to the unaudited Condensed Consolidated Financial Statements included in this Quarterly Report for more information and updates.

**Item 1A. Risk Factors**

There have been no material changes in the risk factors from those set forth in Part I, Item 1A, *Risk Factors* of our 2025 Annual Report.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

**Recent Purchases of Equity Securities by the Issuer and Affiliated Purchases**

The following table provides information about purchases by the Company during the three months ended March 31, 2026 of equity securities of the Company:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares Purchased** | **Average Price Paid Per Share** | **Total Number of Shares Purchased as Part of a Publicly Announced Repurchase Program** | **Approximate Dollar Value of Shares that May Yet be Purchased Under the Repurchase Program**<sup>(1)</sup> *(in millions)* |
| January 1 - January 31 | 3071 | $24.98 | 3071 | $556 |
| February 1 - February 28 |  | $— |  | $556 |
| March 1 - March 31 |  | $— |  | $556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total** | 3071 | $24.98 | 3071 |  |

---

<sup>(1)</sup> *In November 2021, our Board of Directors increased the authorization under the Company's stock repurchase program to $750 million. The approximate dollar value of shares that may be purchased under the program is inclusive of any applicable brokers fees and excise tax and represents the value of shares available under the program at the end of the respective month presented. The program does not require the repurchase of any specific number of shares and shares repurchases are made opportunistically at the discretion of the Company. The program does not have an expiration date but may be suspended or terminated by the Board at any time.*

Shares withheld by the Company to satisfy tax withholding requirements related to the vesting of RSUs are not considered share repurchases under our stock repurchase program.

**Item 3. Defaults Upon Senior Securities**

None

**Item 4. Mine Safety Disclosures**

None

**Item 5. Other Information**

*Director and Officer 10b5-1 Trading Arrangements*

None

------

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** 

The following exhibits are filed or furnished as part of this Quarterly Report:

---

| | |
|:---|:---|
| **Exhibit<br>Number** | **Description** |
| 3.1(a) | <u>[Certificate of Incorporation dated January 22, 2014](https://www.sec.gov/Archives/edgar/data/1590714/000119312514020574/d622226dex31.htm)</u> (filed as Exhibit 3.1 of Post-Effective Amendment No. 1 to the Registration Statement on Form S-4 (File No. 333-192778) filed on January 24, 2014, and incorporated herein by reference) |
| 3.1(b) | <u>[Certificate of Amendment of Certificate of Incorporation dated June 12, 2014](https://www.sec.gov/Archives/edgar/data/1590714/000117184314002820/exh_31.htm)</u> (filed as Exhibit 3.1 of the Current Report on Form 8-K filed on June 13, 2014, and incorporated herein by reference) |
| 3.1(c) | <u>[Certificate of Amendment of Certificate of Incorporation dated January 31, 2019](https://www.sec.gov/Archives/edgar/data/1590714/000114420419005055/tv511849_ex3-1.htm)</u> (filed as Exhibit 3.1 of the Current Report on Form 8-K filed on February 5, 2019, and incorporated herein by reference) |
| 3.2 | <u>[Amended and Restated By-laws](https://www.sec.gov/Archives/edgar/data/1590714/000159071423000045/esi10-q2023331exx32.htm)dated April 25, 2023</u> (filed as Exhibit 3.2 of the Quarterly Report on Form 10-Q filed on April 27, 2023, and incorporated herein by reference) |
| 31.1\* | <u>[Principal Executive Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](esi10-q2026331exx311.htm)</u> |
| 31.2\* | <u>[Principal Financial Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](esi10-q2026331exx312.htm)</u> |
| 32.1\*\* | <u>[Principal Executive Officer and Principal Financial Officer Certifications pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002](esi10-q2026331exx321.htm)</u> |
| 10.1\*\*\* | <u>[Amendment No.10 to Credit Agreement, dated February 2, 2026](https://www.sec.gov/Archives/edgar/data/1590714/000159071426000003/esi8-k22026exx101.htm)</u>, among, inter alios, the Company, MacDermid, Incorporated, the subsidiaries of the Company from time to time parties thereto, the lenders from time to time parties thereto, and Citibank, N.A., as administrative and collateral agent (filed as Exhibit 10.1 of the Current Report on Form 8-K filed on February 2, 2026, and incorporated herein by reference) |
| 101.SCH\*\* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL\*\* | Inline XBRL Extension Calculation Linkbase Document |
| 101.DEF\*\* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB\*\* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE\*\* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 101. INS\*\* | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL documents |
| 104\*\* | Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibits 101) |

---

\*&nbsp;&nbsp;&nbsp;&nbsp;Filed herewith.

\*\* &nbsp;&nbsp;&nbsp;&nbsp;Furnished herewith.

\*\*\*&nbsp;&nbsp;&nbsp;&nbsp;Certain schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule or exhibit will be furnished supplementally to the SEC upon request.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized this April 29, 2026.

---

| | |
|:---|:---|
| ELEMENT SOLUTIONS INC | ELEMENT SOLUTIONS INC |
| By: | /s/ Michael Russnok |
|  | Michael Russnok |
|  | Chief Accounting Officer |
|  | (Principal Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Principal Executive Officer**

**Pursuant to Section 302 of Sarbanes-Oxley Act of 2002**

I, Benjamin Gliklich, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of Element Solutions Inc;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | April 29, 2026 |
| /s/ Benjamin Gliklich | /s/ Benjamin Gliklich |
| Benjamin Gliklich | Benjamin Gliklich |
| Chief Executive Officer | Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**Certification of Principal Financial Officer**

**Pursuant to Section 302 of Sarbanes-Oxley Act of 2002**

I, Carey J. Dorman, certify that:

1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of Element Solutions Inc;

2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: | April 29, 2026 |
| /s/ Carey J. Dorman | /s/ Carey J. Dorman |
| Carey J. Dorman | Carey J. Dorman |
| Executive Vice President, Chief Financial Officer | Executive Vice President, Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION**

**OF**

**CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

I, Benjamin Gliklich, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Element Solutions Inc on Form 10-Q for the fiscal quarter ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Element Solutions Inc.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;Date: | &nbsp;&nbsp;&nbsp;April 29, 2026 |
| &nbsp;&nbsp;&nbsp;By: | &nbsp;&nbsp;&nbsp;/s/ Benjamin Gliklich |
| &nbsp;&nbsp;&nbsp;Name: | &nbsp;&nbsp;&nbsp;Benjamin Gliklich |
| &nbsp;&nbsp;&nbsp;Title: | &nbsp;&nbsp;&nbsp;Chief Executive Officer |

---

I, Carey J. Dorman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Element Solutions Inc on Form 10-Q for the fiscal quarter ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Element Solutions Inc.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;Date: | &nbsp;&nbsp;&nbsp;April 29, 2026 |
| &nbsp;&nbsp;&nbsp;By: | &nbsp;&nbsp;&nbsp;/s/ Carey J. Dorman |
| &nbsp;&nbsp;&nbsp;Name: | &nbsp;&nbsp;&nbsp;Carey J. Dorman |
| &nbsp;&nbsp;&nbsp;Title: | &nbsp;&nbsp;&nbsp;Executive Vice President, Chief Financial Officer |

---

<br>